O n a freezing night in January, several hundred people came to Boston’s Museum of Science for a town hall-style discussion ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino ...

The coronavirus pandemic arrived in Austria five years ago. On February 25, 2020, the first SARS-CoV-2 cases were confirmed ...

Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.

US stock futures edged lower Tuesday, as investors digested China’s retaliation with tariffs against the US as well as more ...

(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of ...

Detailed price information for Realty Income Corp (O-N) from The Globe and Mail including charting and trades.

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...